![](https://florezlab.mgh.harvard.edu/wp-content/uploads/2017/10/Picture1-e1507728101337.png)
The Patients with Hyperglycemia Assessed for Response to Medications by Genetics study is a retrospective clinical cohort of several thousand participants with T2D culled from electronic medical record databases where prescription information and glycemic response is available. Volunteers provide a DNA sample and pharmacogenetic assessments of drug response in a real world setting can be performed.